Ocular Complications From Cancer Therapy - Patient Registry and Biobank

Inclusion Criteria for the Cancer Therapy Group:

* Adult patients (greater than 18 years of age)
* Deny a history of eye diseases (excluding cataract, glaucoma, mild dry eye disease, or history of cataract or refractive surgery)
* Patients who have a history of allogenic HSCT with all stem cell sources including bone marrow, PBSC, cord AND/OR patients with a history of prior cancer therapy including BMT, chemotherapy, and immunotherapy
* Patients will be recruited after their HSCT or cancer therapy at their ophthalmology appointment
* Patients can be included with a history of prior cancer therapy including chemotherapy, BMT, immunotherapy. Prior cancer therapy must be identified and documented.
* The patient must be able to understand and sign and date the informed consent form approved by the IRB.

Inclusion Criteria for the Control Group:

* No history of cancer or cancer therapy in the past
* Adult patients (greater than 18 years of age)
* Deny a history of eye diseases (excluding cataract, glaucoma, mild dry eye disease, or history of cataract or refractive surgery)
* The patient must be able to understand and sign and date the informed consent form approved by the IRB.

Exclusion Criteria for the Cancer Therapy Group:

* Vulnerable populations: neonates, children, prisoners, institutionalized individuals
* Inability or refusal to provide informed consent.
* History of ocular surgery or ocular disease (except refractive or cataract surgery, mild dry eye disease, or glaucoma).

Exclusion Criteria for the Control Group:

* Vulnerable populations: neonates, children, prisoners, institutionalized individuals
* Inability or refusal to provide informed consent.
* History of ocular surgery or ocular disease (except refractive or cataract surgery, mild dry eye disease, or glaucoma).
* History of cancer or cancer therapy including chemotherapy, immunotherapy, BMT.